ArticleMicrobiology spectrum2025
Enrichment and characterization of steroid-degrading microbes for targeted removal of steroid hormone micropollutants in small-scale wastewater treatment solutions.
Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
In remote areas, wastewater treatment typically occurs directly at the source in decentralized systems, which often work well in removing biochemical oxygen demand, nitrogen, and phosphorus, but not micropollutants like pharmaceuticals and steroid hormones. Microorganisms capable of degrading such micropollutants could be used in bioengineered systems to increase micropollutant removal. In this study, bacteria were enriched from municipal wastewater in flow-through reactors supplemented with testosterone (TE), androsta-1,4-dien-3,17-dion (ADD), 17β-estradiol (E2), or 17α-ethinylestradiol (EE2). The removal of TE and ADD was stable over multiple transfers, and several androgen-degrading
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.